| Previous Close | 48.98 |
|---|---|
| Volume | 91,002 |
| Day's Range | 48.39 - 49.14 |
| 52-Week Range | 35.29 - 49.80 |
| Year-to-Date Return | 11.46% |
|---|---|
| 1-Year Return | 15.81% |
| 3-Year Annualized Return | -3.24% |
| 5-Year Annualized Return | 2.34% |
| Expense Ratio | 0.48 |
|---|---|
| Net Assets | $ 440 mil |
| Alpha | 0.08 |
| R-Squared | 0.68 |
| Dividend (Yield) | $0.72 (2.19%) |
| Avg. Market Cap | $ 67,267 mil |
| Beta | 0.67 |
| Price/Earnings | 17.08 |
| Ex-Dividend Date | 6/22/2009 |
| Turnover | 8.00 |
| Standard Deviation | 4.57 |
| Price/Book | 4.72 |
| Management Company | Barclays Global Fund Advisors |
| Administrator | Barclays Global Fund Advisors |
| Company of Name | % of Total | # of Shares Held |
|---|---|---|
| 1. Johnson & Johnson | 8.55% | 626,228 |
| 2. Novartis AG | 6.31% | 601,224 |
| 3. Pfizer | 5.79% | 1,534,080 |
| 4. Roche Holding AG | 5.75% | 159,800 |
| 5. GlaxoSmithKline PLC | 5.22% | 1,179,136 |
| 6. Sanofi-Aventis SA | 3.61% | 235,188 |
| 7. Abbott Laboratories | 3.59% | 351,372 |
| 8. Merck | 3.51% | 479,400 |
| 9. AstraZeneca PLC | 3.44% | 329,188 |
| 10. Wyeth | 3.28% | 303,056 |
| % of Total Holdings | 49.05% |